Randox Life Sciences Release New Antibody Drug Products

Feb. 21, 2011 - PRLog -- Crumlin, UK, 17 February 2011

RANDOX LIFE SCIENCES RELEASE NEW ANTIBODY DRUG PRODUCTS
Products available in bulk for assay development

Randox Life Sciences has developed and manufactured a wide range of products including high quality antibodies and conjugates targeting drugs of abuse, steroids, hormones and biochemical markers. Situated in our state of the art ISO 13485 certified manufacturing plant in the United Kingdom Randox Life Sciences can also provide customers with an extensive list of human recombinant cytokines, chemokines, adhesion molecules and tumour markers.

Our extensive range currently consists of more than 1000 products and is set to expand with the launch of several new antibodies and corresponding conjugates to meet the future needs of the research and development markets.  To promote our new range of antibodies Randox Life Sciences are offering a free corresponding HRP conjugate with each online order. Bulk order antibodies are also available for assay development.  New markers of interest include:

•   7-Aminoflunitrazepam
•   Azaperone
•   Carbamazepine
•   Cotinine
•   Dehydronorketamine
•   Dextromethorphan
•   Dienestrol
•   Diethylstilbestrol
•   Ethylglucuronide
•   Haloperidol
•   HGF-A
•   Hydroxyindole acetic acid
•   Human IgG
•   LP-PLA2
•   ANTI-HEROIN
•   Mephedrone
•   Mescaline
•   Norsertraline
•   Triamcinolone Acetonide
•   Zearalanone & Zearalanol
•   Zopiclone, Zaleplon &  Zolpidem

Our complete range of polyclonal antibodies are suitable for use in the development of in-house detection methods and offer the following benefits:

•   High sensitivity
•   High concentration
•   Excellent specificity to target compound
•   Detailed cross reactivity profiles
•   Available for bulk purchase
•   Stable when stored at -20oC
•   Excellent reproducibility between lot numbers
•   Matching HRP labelled conjugates

For more information please visit http://www.randox-lifesciences.com/

About Randox  
Headquartered in the United Kingdom, Randox Laboratories Ltd. is a market leader within the in vitro diagnostics industry, manufacturing high quality diagnostic products for laboratories worldwide. Our extensive product portfolio offers complete solutions within the fields of clinical chemistry, cardiology, forensic toxicology, veterinary, drug residues, life sciences, oncology, molecular diagnostics and internal and external quality control. Our goal is to ‘revolutionise healthcare through continuously improving diagnostic solutions.’ We continue to achieve this year after year due to our commitment and significant re-investment in Research and Development. Our innovative approach to diagnostics allows us to develop revolutionary products, specifically designed to provide more efficient, higher quality and reliable results, ensuring patients receive the right diagnosis at the right time.

For more information contact us at lifesciences@randox.com

# # #

Randox Laboratories are market leaders in the diagnostics field. The range of products includes, Biochip Array Technology, clinical chemistry analysers and reagents, quality control materials and an extensive life science portfolio.